Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

Public health officials are concerned that we could move back into a situation like that of the early 20th century, before ...

it will be the first antibiotic in the beta-lactam class to or the treatment of SAB S. aureus, including hard-to-treat infections caused by methicillin-resistant strains (MRSA), said Basilea.

Scientists who developed the Oxford AstraZeneca vaccine during the Covid pandemic are developing the UK's first bubonic ...

The team behind the Oxford AstraZeneca covid vaccine say they are developing an injection that could prevent the bubonic ...

Hospitals in New Jersey rank fifth best in the nation for protecting patients from injuries and medical errors and preventing ...

Medically reviewed by Susan Bard, MD Having psoriasis, an autoimmune condition that causes inflamed skin patches, can make ...

NDAQ:ACXP) Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules ...